A double-blind trial of 'nethaprin dospan' in chronic asthmatic children.
D000284:Administration, Oral; D001249:Asthma / Q000188:drug therapy* / Q000503:physiopathology; D001993:Bronchodilator Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003692:Delayed-Action Preparations; D004319:Doxylamine / Q000008:administration & dosage / Q000627:therapeutic use / Q000031:analogs & derivatives; D004338:Drug Combinations; D004809:Ephedrine / Q000008:administration & dosage* / Q000627:therapeutic use / Q000031:analogs & derivatives; D005260:Female; D006801:Humans; D008297:Male; D010656:Phenylephrine / Q000008:administration & dosage* / Q000627:therapeutic use; D010919:Placebos; D011412:Propanolamines / Q000008:administration & dosage* / Q000627:therapeutic use; D011725:Pyridines / Q000008:administration & dosage*; D012119:Respiration / Q000187:drug effects; D012129:Respiratory Function Tests; D013806:Theophylline / Q000008:administration & dosage* / Q000627:therapeutic use / Q000031:analogs & derivatives
D001993:Bronchodilator Agents; D003692:Delayed-Action Preparations; D004338:Drug Combinations; D010919:Placebos; D011412:Propanolamines; D011725:Pyridines; D010656:Phenylephrine; C008602:nethaprin dospan; D004319:Doxylamine; D013806:Theophylline; D004809:Ephedrine